MARC

Tag First Indicator Second Indicator Subfields
LEADER 00000cam a2200000Ia 4500
001 in00002658721
005 20260414160611.2
006 m d
007 cr cn|
008 100813s2005 njua ob 001 0 eng d
010 |a  2004027653 
019 |a 190751584  |a 234543365 
020 |a 158829451X 
020 |a 1592598714 
020 |a 9781588294517 
020 |a 9781592598717 
035 |a (OCoLC)655853894  |z (OCoLC)190751584  |z (OCoLC)234543365 
035 |a (OCoLC)ocn655853894 
035 |a 3799982 
037 |a 978-1-58829-451-7  |b Springer  |n http://www.springerlink.com 
040 |a GW5XE  |b eng  |c GW5XE  |d HNK  |d YNG  |d UtOrBLW 
049 |a TXAC 
050 1 4 |a RC889  |b .O73 2005 
060 1 4 |a 2005 E-228 
060 1 4 |a WJ 709  |b O63 2005 
082 0 4 |a 616.6/922061  |2 22 
245 0 0 |a Oral pharmacotherapy for male sexual dysfunction :  |b a guide to clinical management /  |c edited by Gregory A. Broderick. 
264 1 |a Totowa, N.J. :  |b Humana Press,  |c [2005] 
264 4 |c ©2005 
300 |a xii, 457 pages :  |b illustrations ;  |c 23 cm. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Current clinical urology 
500 |a Electronic resource. 
504 |a Includes bibliographical references and index. 
505 0 |a Physiology and pharmacology of erectile dysfunction / Rafael Carrion ... [et al.] -- Epidemiology of erectile dysfunction / Jonathan D. Schiff and John P. Mulhall -- Pharmacology of phosphodiesterase inhibitors / Erwin Bischoff -- Sildenafil citrate, the classical PDE5 inhibitor: a five-year review of its efficacy and safety in the arena of erectile dysfunction / Harin Padma-Nathan -- Tadalafil: clinical trials experience / Culley C. Carson, III -- Vardenafil: clinical trials experience / Ajay Nehra -- Erectile dysfunction assessment and management in primary care practice / Louis Kuritzky and Martin Miner -- When to refer the patient with erectile dysfunction to a specialist / Ira D. Sharlip -- Erectile dysfunction: assessing risk and managing the cardiac patient / Thorsten Reffelmann and Robert A. Kloner -- Is diabetic erectile dysfunction more difficult to treat? / Pierre Theuma and Vivian A. Fonseca -- Depression and antidepressant-associated erectile dysfunction / Raymond C. Rosen -- Intracavernous, transurethral, and topical therapies for erectile dysfunction in the era of oral pharmacotherapy: salvaging first-line therapy, failures with combination therapies / Hans-Martin A. Fritsche, Mustafa F. Usta, and Wayne J.G. Hellstrom -- Androgen deficiency of the aging male: enhancing erectile response to oral pharmacotherapy / Alvaro Morales and Jeremy P.W. Heaton -- Central activation of erection and clinical experience / Jeremy P.W. Heaton, Alvaro Morales, and Michael A. Adams -- Sustaining the cure: oral pharmacotherapy failures salvage with vacuum devices and penile implants / Ronald W. Lewis -- Prevention and treatment of erectile dysfunction utilizing lifestyle changes and dietary supplements: what works and what is worthless? / Mark A. Moyad -- Pharmacological strategies in the management of rapid ejaculation / Chris G. McMahon -- Sexual dysfunction after radical prostatectomy and the use of PDE-5 inhibitors / Andrew McCullough -- Female sexual dysfunction: is there a magic pill? / Ridwan Shabsigh ... [et al.]. 
506 |a Access restricted to subscribers. 
533 |a Electronic reproduction.  |b New York :  |c Springer,  |d 2010.  |n Mode of access: World Wide Web.  |n System requirements: Web browser.  |n Title from title screen (viewed on Aug. 9, 2010).  |n Access may be restricted to users at subscribing institutions. 
538 |a Mode of access: World Wide Web. 
650 1 2 |a Impotence, Vasculogenic  |x drug therapy.  |0 https://id.nlm.nih.gov/mesh/D018783Q000188 
650 2 2 |a Phosphodiesterase Inhibitors  |x therapeutic use.  |0 https://id.nlm.nih.gov/mesh/D010726Q000627 
650 2 2 |a Salvage Therapy  |x methods.  |0 https://id.nlm.nih.gov/mesh/D016879Q000379 
650 2 2 |a Vasodilator Agents  |x therapeutic use.  |0 https://id.nlm.nih.gov/mesh/D014665Q000627 
650 0 |a Cyclic nucleotide phosphodiesterases  |x Inhibitors  |x Therapeutic use. 
650 0 |a Impotence  |x Chemotherapy. 
650 0 |a Impotence.  |0 http://id.loc.gov/authorities/subjects/sh85064658 
650 6 |a Impuissance sexuelle  |x Chimiothérapie. 
650 6 |a Impuissance sexuelle. 
650 6 |a Nucléotides cycliques phosphodiestérases  |x Inhibiteurs  |x Emploi en thérapeutique. 
655 7 |a Electronic books.  |2 local 
700 1 |a Broderick, Gregory A.  |0 http://id.loc.gov/authorities/names/n2005013452 
710 2 |a SpringerLink (Online service)  |0 http://id.loc.gov/authorities/names/no2005046756 
776 1 |c Original  |z 158829451X  |z 9781588294517  |z 1592598714  |z 9781592598717  |w (DLC) 2004027653  |w (OCoLC)57044110 
830 0 |a Current clinical urology.  |0 http://id.loc.gov/authorities/names/n99801681 
856 4 0 |u http://proxy.library.tamu.edu/login?url=https://dx.doi.org/10.1385/1592598714  |z Connect to the full text of this electronic book  |t 0 
994 |a 92  |b TXA 
999 |a MARS 
999 f f |s 3113aac6-1a06-39d2-87e0-e82a89ae4ddc  |i 7de5697d-76c0-3deb-8a16-96b3b61ef8a9  |t 0 
952 f f |a Texas A&M University  |b College Station  |c Electronic Resources  |s www_evans  |d Available Online  |t 0  |e RC889 .O73 2005  |h Library of Congress classification 
998 f f |a RC889 .O73 2005  |t 0  |l Available Online